29 episodes

The Elixir Factor podcast brings researchers together with industry leaders, advocacy groups, patients, and their loved ones to discuss how Lilly tackles the world’s most significant health challenges. Tune in as we unpack complex science and innovative breakthroughs that can make life better for people around the world.

The Elixir Factor Eli Lilly and Company

    • Science
    • 5.0 • 43 Ratings

The Elixir Factor podcast brings researchers together with industry leaders, advocacy groups, patients, and their loved ones to discuss how Lilly tackles the world’s most significant health challenges. Tune in as we unpack complex science and innovative breakthroughs that can make life better for people around the world.

    S4 Ep7: Utilizing Technology to Monitor Patient Safety and Improve Patient Experience in Clinical Trials – Part 1

    S4 Ep7: Utilizing Technology to Monitor Patient Safety and Improve Patient Experience in Clinical Trials – Part 1

    • 17 min
    S4 Ep6: Jim & Geri Taylor: Fighting Alzheimer’s Disease with Courage and Resilience

    S4 Ep6: Jim & Geri Taylor: Fighting Alzheimer’s Disease with Courage and Resilience

    More than six million people currently live with Alzheimer’s disease and an additional five thousand are undiagnosed. Fighting and advocating for a disease without any treatment requires courage and resilience – as well as kindness and patience in the face of fear. On this episode of The Elixir Factor, Jim and Geri Taylor share their story of fighting this disease with courage and resilience, and finding ways to appreciate life together despite a chronic diagnosis.

    • 20 min
    S4 Ep5: The X Factor- Up Close & Personal with Michelle Lynn Hall, associate vice president of genetic medicine

    S4 Ep5: The X Factor- Up Close & Personal with Michelle Lynn Hall, associate vice president of genetic medicine

    • 14 min
    S4 Ep4: Breast Cancer in the Black Community: What Women Should Know- Part 2 with Dr. Stacy Moulder

    S4 Ep4: Breast Cancer in the Black Community: What Women Should Know- Part 2 with Dr. Stacy Moulder

    • 15 min
    S4 Ep3: Breast Cancer in the Black Community- What Women Should Know: Part 1 with Lisa Hayes and Iman Mangum

    S4 Ep3: Breast Cancer in the Black Community- What Women Should Know: Part 1 with Lisa Hayes and Iman Mangum

    • 24 min
    S4 Ep2: The Power of Decentralized Clinical Trials: What You Should Know

    S4 Ep2: The Power of Decentralized Clinical Trials: What You Should Know

    When the COVID-19 pandemic hit, it changed the way we operate across countless areas of our lives. Now, many people are assessing what changes should remain moving forward. At Lilly, where we’re focused on developing medicines that will make life better for people around the world, we’re harnessing what we’ve learned to advance our work and asking ourselves: What lessons from the pandemic can we apply to improve clinical trials? The answer: Quite a few.

    On this episode of The Elixir Factor, guest host Phyllis Ferrell, global head of Alzheimer’s disease external engagement at Lilly, explores how the disruptions caused by the COVID-19 pandemic are providing new ways for us to think about clinical trials and our work to discover breakthrough medicines. Janelle Sabo, PharmD, vice president of Clinical Research Capabilities at Lilly, shares her perspective on how Lilly’s approach to clinical trials started shifting pre-pandemic and how COVID-19 impacted that work. Jessica Langbaum, PhD, director of Alzheimer’s Prevention Initiative led by Banner Alzheimer’s Institute and Jared Brosch, MD, Indiana University School of Medicine, also join the conversation to talk about how a decentralized approach to clinical trials can advance the science and increase patient access, specifically to cutting-edge Alzheimer’s disease clinical trials.

    The group explores how key learnings from the last two years, coupled with recent clinical trial innovations, give us a new path forward to make trials more accessible and expansive, so more people have access to innovative, life-changing new medicines.

    • 22 min

Customer Reviews

5.0 out of 5
43 Ratings

43 Ratings

Team RLS ,

Episode 7

I just listened to Episode 7 regarding the advancement of technology and innovation in managing Type 1 diabetes. The guests provide eye-opening insights into the personal struggles those with the disease face 24-hours a day for life. It’s fascinating to hear about the human drive to bridge the gap in understanding of technological limitations (and possibilities) between patients and researchers.

Ryan S.
Westfield, IN

SaumiRa ,

Joe is amazing

Have been a big fan of Joe’s work through out the years and listening to him via this podcast is icing on the cake ! Wishing Joe the very best

You Might Also Like

Hidden Brain
Harvard Business Review
STAT
theSkimm
Cadence13
NPR